Vitamin c boosts radiation for sarcoma? early trial shows promise
NCT ID NCT03508726
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether giving high-dose vitamin C (ascorbate) alongside radiation therapy before surgery is safe and effective for people with advanced soft tissue sarcoma. 25 participants received vitamin C infusions three times a week during radiation. The goal was to see if the combination could kill more tumor cells and improve outcomes. Results are still being analyzed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- high-dose vitamin C (ascorbate) given intravenously
- What this could lead to
- If it works, this could point toward a way to make radiation more effective for soft tissue sarcoma, potentially improving tumor shrinkage before surgery.
- What could go wrong
- This was a small, early-phase trial with only 25 participants, so results may not apply to everyone. High-dose vitamin C can cause side effects like kidney issues or electrolyte imbalances.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive antibody light up hidden tumors?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Could a massive tissue bank unlock sarcoma's secrets?
- Can a targeted pill stall advanced sarcomas?
- Protein-Wrapped chemo aims to hit tumors harder, spare healthy cells
- Drug duo takes on rare head and neck tumors